title: No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma.
abstract: Neuroblastoma occasionally occurs in diseases associated with abnormal neurocrest differentiation, e.g. Hirschsprung disease. Expression studies in developing mice suggest that the proto-oncogene RET plays a role in neurocrest differentiation. In humans expression of RET is limited to certain tumor types, including neuroblastoma, that derive from migrating neural crest cells. Mutations of RET are found associated with Hirschsprung disease. These data prompted us to investigate expression of RET and to search for gene mutations in neuroblastoma. Out of 16 neuroblastoma cell lines analyzed, 9 show clear expression of RET in a Northern blot analysis. In a single strandt conformation polymorphism (SSCP) analysis of all exons, no mutations were detected other than neutral polymorphisms. In a patient with neuroblastoma, from a family in which different neurocrestopathies, including neuroblastoma and Hirschsprung disease, had occurred, we also failed to detect RET mutations. Possibly, expression of RET in neuroblastoma merely reflects the differentiation status of the tumor cells. The absence of mutations suggests that RET does not play a crucial role in the tumorigenesis of neuroblastoma.
authors.affiliation: University of Groningen, Department of Medical Genetics, The Netherlands.
authors.forename: R M
authors.initials: RM
authors.lastname: Hofstra
authors.forename: N C
authors.initials: NC
authors.lastname: Cheng
authors.forename: C
authors.initials: C
authors.lastname: Hansen
authors.forename: R P
authors.initials: RP
authors.lastname: Stulp
authors.forename: T
authors.initials: T
authors.lastname: Stelwagen
authors.forename: N
authors.initials: N
authors.lastname: Clausen
authors.forename: N
authors.initials: N
authors.lastname: Tommerup
authors.forename: H
authors.initials: H
authors.lastname: Caron
authors.forename: A
authors.initials: A
authors.lastname: Westerveld
authors.forename: R
authors.initials: R
authors.lastname: Versteeg
authors.forename: C H
authors.initials: CH
authors.lastname: Buys
mesh_terms: D029721:Drosophila Proteins; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000235:genetics*; D009447:Neuroblastoma / Q000235:genetics*; D018807:Polymorphism, Single-Stranded Conformational; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics*
chemical_list: D029721:Drosophila Proteins; C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases; C416649:Ret protein, Drosophila